Cannabis Research

      Insys Therapeutics, the Arizona-based pharmaceutical company that recently became the biggest financial supporter of the campaign against marijuana legalization in that state, makes an oral spray that delivers the opioid painkiller fentanyl and plans to […] Source: Medical Marijuana Seems To Reduce Deaths From Pharmaceuticals

Medical Marijuana Seems To Reduce Deaths From Pharmaceuticals|Forbes

  As states grapple with the re-integration of medical cannabis into the physician’s compendium, there are hundreds of small dramas being played out all across the nation, indeed all around the globe. Many go unreported except for local coverage. The process isn’t as sexy as tie-dyed hippies with mammoth bongs […]

Sensible Minnesota: Using Medical Cannabis for Chronic Pain | Cannabis ...

A researcher in Israel is preparing to study the potential beneficial effects of cannabidiol (CBD) on children and adults with autism. Source: Israeli Doctor to Study Cannabis’s Effect on Autism – Medical Marijuana Inc. (OTC: MJNA) Editor’s note: Autism is complex, to say the least, and researching the effects of […]

Israeli Doctor to Study Cannabis’s Effect on Autism – Medical ...

Glaucoma is an irreversible blinding eye disease which produces progressive retinal ganglion cell (RGC) loss. Intraocular pressure (IOP) is currently the only modifiable risk factor, and lowering IOP results in reduced risk of progression of the disorder. The endocannabinoid system (ECS) has attracted considerable attention as a potential target for […]

The Endocannabinoid System as a Therapeutic Target in Glaucoma|Neural Plasticity

Ethan Russo forwards a slightly revised “Beyond Cannabis: Plants and the endocannabinoid system,” published in Trends in Pharmacological Sciences, with “the hope that this will raise consciousness on the endocannabinoid system and its importance and ubiquity.”Russo was an early proponent of the idea that an overall endocannabinoid deficiency —insufficient “endocannabinoid […]

Ethan Russo Looks ‘Beyond Cannabis’ | O’Shaughnessy’s

The CB2 receptor is one of the components of the endogenous cannabinoid system, a complex network of signaling molecules and receptors involved in the homeostatic control of several physiological functions. Accumulated evidence suggests a role for CB2 receptors in Alzheimer’s disease (AD) and indicates their potential as a therapeutic target […]

CB2 Cannabinoid Receptor As Potential Target against Alzheimer’s Disease| PubMed ...